ES2182061T3 - 1 - (2 - desoxi - 2 - fluor-4- tio-beta-d arabinofuranosil)citosina. - Google Patents

1 - (2 - desoxi - 2 - fluor-4- tio-beta-d arabinofuranosil)citosina.

Info

Publication number
ES2182061T3
ES2182061T3 ES97916633T ES97916633T ES2182061T3 ES 2182061 T3 ES2182061 T3 ES 2182061T3 ES 97916633 T ES97916633 T ES 97916633T ES 97916633 T ES97916633 T ES 97916633T ES 2182061 T3 ES2182061 T3 ES 2182061T3
Authority
ES
Spain
Prior art keywords
beta
citosine
desoxi
arabinofuranosil
fluor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97916633T
Other languages
English (en)
Spanish (es)
Inventor
Yuichi Yoshimura
Kenji Kitano
Shinji Miura
Haruhiko Machida
Mikari Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamasa Corp
Original Assignee
Yamasa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamasa Corp filed Critical Yamasa Corp
Application granted granted Critical
Publication of ES2182061T3 publication Critical patent/ES2182061T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES97916633T 1996-04-09 1997-04-09 1 - (2 - desoxi - 2 - fluor-4- tio-beta-d arabinofuranosil)citosina. Expired - Lifetime ES2182061T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11196896 1996-04-09
JP21508296 1996-07-26
JP27863196 1996-09-30

Publications (1)

Publication Number Publication Date
ES2182061T3 true ES2182061T3 (es) 2003-03-01

Family

ID=27312140

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97916633T Expired - Lifetime ES2182061T3 (es) 1996-04-09 1997-04-09 1 - (2 - desoxi - 2 - fluor-4- tio-beta-d arabinofuranosil)citosina.

Country Status (10)

Country Link
US (1) US6147058A (cs)
EP (1) EP0841344B1 (cs)
JP (1) JP3657008B2 (cs)
AT (1) ATE224909T1 (cs)
CA (1) CA2224155C (cs)
DE (1) DE69715774T2 (cs)
DK (1) DK0841344T3 (cs)
ES (1) ES2182061T3 (cs)
PT (1) PT841344E (cs)
WO (1) WO1997038001A1 (cs)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7875733B2 (en) * 2003-09-18 2011-01-25 Isis Pharmaceuticals, Inc. Oligomeric compounds comprising 4′-thionucleosides for use in gene modulation
US7138384B1 (en) 1997-08-29 2006-11-21 The Regents Of The University Of California Modulators of DNA cytosine-5 methyltransferase and methods for use thereof
ATE344271T1 (de) * 1998-02-25 2006-11-15 Univ Emory 2'-fluoronukleoside
US7524831B2 (en) * 2005-03-02 2009-04-28 Schering Corporation Treatments for Flaviviridae virus infection
TWI476204B (zh) 2009-12-18 2015-03-11 Libramedicina Inc 製備經取代之１－Ｏ－醯基－２－脫氧－２－氟－４－硫－β－Ｄ－阿拉伯呋喃糖的製程
EP2388257A1 (en) 2010-05-20 2011-11-23 LibraMedicina, Inc. Process for preparing substituted 1-O-acyl-2-deoxy-2-fluoro-4-thio-ß-D-arabinofuranoses
CN104203969B (zh) * 2012-03-28 2016-08-31 富士胶片株式会社 1-(2-脱氧-2-氟-4-硫代-β-D-阿拉伯呋喃糖基)胞嘧啶的盐
HRP20190572T1 (hr) * 2012-08-13 2019-05-17 Fujifilm Corporation POSREDNIK ZA SINTEZU 1-(2-DEOKSI-2 FLUORO-4-TIO-beta-D-ARABINOFURANOZIL) CITOZINA, POSREDNIK ZA SINTEZU TIONUKLEOZIDA, I METODE ZA PROIZVODNJU OVIH POSREDNIKA
WO2014197578A1 (en) * 2013-06-05 2014-12-11 Idenix Pharmaceuticals, Inc. 1',4'-thio nucleosides for the treatment of hcv
WO2015125781A1 (ja) * 2014-02-18 2015-08-27 富士フイルム株式会社 チオラン骨格型糖化合物の製造方法およびチオラン骨格型糖化合物
JP6351107B2 (ja) * 2014-02-18 2018-07-04 富士フイルム株式会社 チオラン骨格型糖化合物の製造方法およびチオラン骨格型糖化合物
JP6204223B2 (ja) 2014-02-19 2017-09-27 富士フイルム株式会社 チオピラノース化合物等の製造方法
TWI678373B (zh) 2014-10-31 2019-12-01 日商富士軟片股份有限公司 硫代核苷衍生物或其鹽及醫藥組合物
JP6769000B2 (ja) 2015-04-03 2020-10-14 シチュアン ケルン−バイオテック バイオファーマシューティカル カンパニー リミテッド ４’−チオヌクレオシドの新規な化合物、並びにその調製方法、その医薬組成物及びその用途
JP6450356B2 (ja) 2016-02-29 2019-01-09 富士フイルム株式会社 液状医薬製剤
RU2752172C2 (ru) * 2016-08-31 2021-07-23 Фуджифилм Корпорэйшн Противоопухолевый агент, усилитель противоопухолевого действия и противоопухолевый набор
EA201990780A1 (ru) 2016-12-22 2019-11-29 Твердая форма соединения 4'-тио-2'-фторнуклеозид фосфамида и способ его получения и применения
CN110831604B (zh) * 2017-09-01 2023-05-02 四川科伦博泰生物医药股份有限公司 用于肿瘤治疗或预防的药物组合物、方法及其用途
TW201932119A (zh) 2018-01-29 2019-08-16 日商富士軟片股份有限公司 膽道癌用抗腫瘤劑和膽道癌的處理方法
WO2019146129A1 (ja) * 2018-01-29 2019-08-01 富士フイルム株式会社 イソクエン酸デヒドロゲナーゼ変異を有する腫瘍に対する医薬組成物および抗腫瘍剤ならびにその利用
WO2019164010A1 (ja) * 2018-02-26 2019-08-29 富士フイルム株式会社 膀胱がん用抗腫瘍剤および膀胱がんの処置方法
CN111836628B (zh) * 2018-03-13 2025-01-07 富士胶片株式会社 抗肿瘤剂、抗肿瘤效果增强剂及抗肿瘤用试剂盒
CA3110224A1 (en) * 2018-09-25 2020-04-02 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services 2'-halogenated-4'-thio-2'-deoxy-5-azacytidine analogs and use thereof
CN112770731A (zh) * 2018-11-28 2021-05-07 四川科伦博泰生物医药股份有限公司 以4’-硫代核苷类化合物为活性成分的口服药物组合物、其制备方法及其用途
CA3148866A1 (en) * 2019-07-30 2021-02-04 Pinotbio, Inc. Dinucleotide compounds for treating cancers and medical uses thereof
KR20240028451A (ko) 2021-07-29 2024-03-05 후지필름 가부시키가이샤 Bap1 및 pbrm1 중 적어도 하나의 기능 저하를 갖는 종양에 대한 의약 조성물 및 항종양제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE74701B1 (en) * 1989-10-04 1997-07-30 Univ Birmingham Further antiviral pyrimidine nucleosides
US5811408A (en) * 1994-07-12 1998-09-22 Yamasa Corporation 2'-deoxy-2'-(substituted or unsubstituted)methylidene-4'-thionucleosides
JPH0853490A (ja) * 1994-08-09 1996-02-27 Yamasa Shoyu Co Ltd ２’−デオキシ−２’，２’−ジハロゲノ−４’−チオヌクレオシド

Also Published As

Publication number Publication date
PT841344E (pt) 2003-02-28
DE69715774T2 (de) 2003-05-15
ATE224909T1 (de) 2002-10-15
DK0841344T3 (da) 2002-12-23
JP3657008B2 (ja) 2005-06-08
WO1997038001A1 (en) 1997-10-16
EP0841344A4 (cs) 1998-05-13
DE69715774D1 (de) 2002-10-31
EP0841344B1 (en) 2002-09-25
EP0841344A1 (en) 1998-05-13
CA2224155A1 (en) 1997-10-16
US6147058A (en) 2000-11-14
CA2224155C (en) 2004-10-26

Similar Documents

Publication Publication Date Title
ES2182061T3 (es) 1 - (2 - desoxi - 2 - fluor-4- tio-beta-d arabinofuranosil)citosina.
ZA200309887B (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents.
AU5211686A (en) Pyrazolesulfonamide derivative, process for its production and herbicide containing it
ATE201195T1 (de) Tricyclische verbindungen
SI1385518T1 (sl) Benzimidazolonske spojine
BG103778A (en) Process for preparing pyrazole derivatives
EP0714900A3 (de) Alkylhydrogenchlorsilane, Verfahren zu deren Herstellung und deren Verwendung
ATE277017T1 (de) 1,2-disubstituierte 1,4-dihydro-4-oxochinolin- verbindungen
FI955954A0 (fi) Thiolyhdisteitä
AU2001282297A1 (en) Catalysts
GR3029836T3 (en) Process for producing n-biphenylmethylthiadiazoline derivative or salt thereof and intermediate for producing the same
ATE223414T1 (de) Prozess zur herstellung von zwischebprodukten für imidazodeazepinen
EP0747350A4 (en) PROCESS FOR THE MANUFACTURE OF BIS (4-ALKYLTHIOPHENYLE) BISULFIDE
ATE206125T1 (de) Furoindolizine
EP0551632A3 (en) Process for the preparation of halogenoanthranilic acid
AU2407597A (en) Eyedrops
ATE176242T1 (de) Uck14-verbindungen
DE69615814D1 (de) Uch-15-verbindungen
BR0016521B1 (pt) processo para produÇço de 2-nitroguanidinas 1,3-dissubstituÍdas.
FI904981A0 (fi) Nya inosin/guanosinderivat.
EP1007511A4 (en) PRODUCTION OF BETA MEHTYLCARBAPENEM INTERMEDIATE PRODUCTS